215 related articles for article (PubMed ID: 20842915)
41. [Dynamics of water and sodium in renal insufficiency: in reference to therapeutic classification of disease stages].
Nakagawa S; Yamada T; Kitaoka T; Koshikawa S
Nihon Rinsho; 1974 Mar; 32(3):449-56. PubMed ID: 4603493
[No Abstract] [Full Text] [Related]
42. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
43. [Oxalic acid metabolism in chronic renal failure].
Balcke P
Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
[TBL] [Abstract][Full Text] [Related]
44. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
[TBL] [Abstract][Full Text] [Related]
45. Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients.
Reis PF; da Silva CD; Brunini TM; Moss MB; Siqueira MA; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
J Ren Nutr; 2006 Oct; 16(4):325-31. PubMed ID: 17046616
[TBL] [Abstract][Full Text] [Related]
46. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
47. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
Kopple JD; Gordon SI; Wang M; Swendseid ME
J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
[TBL] [Abstract][Full Text] [Related]
48. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
[TBL] [Abstract][Full Text] [Related]
49. Use of mean spot urine sodium concentrations to estimate daily sodium intake in patients with chronic kidney disease.
Kang SS; Kang EH; Kim SO; Lee MS; Hong CD; Kim SB
Nutrition; 2012 Mar; 28(3):256-61. PubMed ID: 21996048
[TBL] [Abstract][Full Text] [Related]
50. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis.
Mydlík M; Derzsiová K; Svác J; Dlhopolcek P; Zemberová E
Artif Organs; 1998 Sep; 22(9):784-8. PubMed ID: 9754466
[TBL] [Abstract][Full Text] [Related]
51. Urinary excretion of vitamin C in chronic renal failure and after renal transplantation.
Mydlík M; Derzsiová K; Pribylincová V; Zvara V; Takác M
Int Urol Nephrol; 1986; 18(4):457-62. PubMed ID: 3546176
[TBL] [Abstract][Full Text] [Related]
52. Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins.
Klammt S; Wojak HJ; Mitzner A; Koball S; Rychly J; Reisinger EC; Mitzner S
Nephrol Dial Transplant; 2012 Jun; 27(6):2377-83. PubMed ID: 22086973
[TBL] [Abstract][Full Text] [Related]
53. The relationship between colonization of Oxalobacter formigenes serum oxalic acid and endothelial dysfunction in hemodialysis patients: from impaired colon to impaired endothelium.
Turkmen K; Erdur FM
Med Hypotheses; 2015 Mar; 84(3):273-5. PubMed ID: 25630805
[TBL] [Abstract][Full Text] [Related]
54. Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients.
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
Eur J Clin Invest; 1982 Dec; 12(6):481-3. PubMed ID: 6818036
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of dialysis and ultrafiltrate from individuals with CKD, with or without diabetes, on platelet phosphatidylserine externalization.
Wang Y; Beck W; Deppisch R; Marshall SM; Hoenich NA; Thompson MG
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F220-8. PubMed ID: 17670899
[TBL] [Abstract][Full Text] [Related]
56. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
Rolton HA; McConnell KM; Modi KS; Macdougall AI
Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
[TBL] [Abstract][Full Text] [Related]
57. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
Black AP; Cardozo LF; Mafra D
Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
[TBL] [Abstract][Full Text] [Related]
58. Disposition and clinical implications of protein-bound uremic toxins.
Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
[TBL] [Abstract][Full Text] [Related]
59. Future Avenues to Decrease Uremic Toxin Concentration.
Vanholder RC; Eloot S; Glorieux GL
Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
[TBL] [Abstract][Full Text] [Related]
60. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
Pru C; Eaton J; Kjellstrand C
Nephron; 1985; 39(2):112-6. PubMed ID: 3974772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
